-
About FDA
-
CDER Presentations
2008
- CDER Priorities for 2009 December 4, 2008, Janet Woodcock M.D.
- New Drug Review: 2008 Update, December 4, 2008, John K. Jenkins, M.D.
- Importation of Active Pharmaceutical Ingredient (API) Requirements July 16, 2008
2007
- FDA/Small Business Administrations Drug Educational Forum; Public Workshop, April 25, 2007
- Marketed Unapproved Drugs Meeting, January 9, 2007
2006
-
Presentation to the American Public Health Association, November 6, 2006, Steven K. Galson, M.D, M.P.H
-
Steven K. Galson, M.D., M.P.H., announces changes to the process FDA uses to prioritize the review of generic drug applications. Presentation
- 42nd Annual Meeting of the Drug Information Association, June 18-22, 2006, Philadelphia, PA
- Division of Medical Imaging and Hematology Products Presentations at the Annual Society of Nuclear Medicine Meeting, June, 2006
- Cancer Drug Approval Endpoints (presentations from various meetings)
- Division of Drug Marketing, Advertising, and Communications (presentations from various meetings)
- Genomics at FDA
- Hepatotoxicity Steering Group Meeting
- Public Workshop on Emerging Clostridial Disease, May 11, 2006, Atlanta, Georgia
- Small Pharmaceutical Business Educational Forum, Public Workshop, April 25, 2006
- Presentations from the Office of Oncology Drug Products
-
-